Long-Term Protective Effect of N-Acetylcysteine against Amikacin-Induced Ototoxicity in End-Stage Renal Disease: A Randomized Trial

Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
Alperen VuralYaşar Ünlü

Abstract

The aim of the study is to evaluate the long-term protective effect of N-acetylcysteine (NAC), an antioxidant agent, against aminoglycoside (AG)-induced ototoxicity. A total of 40 patients receiving continuous ambulatory peritoneal dialysis (CAPD) and having their first peritonitis attacks and planned to be treated with AGs were enrolled in the study. They were randomized into 2 groups: 1 group received additional NAC and the other did not. All patients underwent hearing tests with pure tone audiometry (PTA) after the diagnosis, at 1 month and 12 months and at the same time the tumor necrosis factor (TNF)-α and interleukin (IL)-6 levels were measured. Patients taking NAC had better hearing test results in both ears at 1 month except 2,000 Hz for the left ear, which wasn't significantly different between the 2 groups. Although patients taking NAC had generally better PTA results at 12 months, differences between the 2 groups were not statistically significant. Baseline IL-6 level was significantly higher in the NAC group than the control group. Both TNF-α and IL-6 levels at 1 month were significantly lower in the NAC group than in the control group. On the other hand, there was no significant difference between the 2 groups in t...Continue Reading

References

Aug 1, 1993·The Journal of Laryngology and Otology·B S GendehZ M Zahir
May 20, 1998·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·J Schacht
Jul 17, 1998·Free Radical Biology & Medicine·B B SongJ Schacht
Jun 8, 2002·Audiology & Neuro-otology·Wei-Jing WuJochen Schacht
May 31, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Roberto Pecoits-FilhoPeter Stenvinkel
Jul 2, 2003·Yonsei Medical Journal·Erol SelimoğluFazli Erdoğan
Jul 15, 2003·Clinical Microbiology Reviews·Sergei B Vakulenko, Shahriar Mobashery
Jul 9, 2004·Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·F Owen BlackValerie Stallings
Jul 27, 2007·Kidney International·M Tepel
Sep 8, 2007·Current Opinion in Otolaryngology & Head and Neck Surgery·Mark Douglas Rizzi, Keiko Hirose
Jun 3, 2008·Toxicology·O'Neil W Guthrie
May 10, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Bulent TokgozCengiz Utas
Oct 10, 2012·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Jochen SchachtLeonard P Rybak
Jun 12, 2013·Expert Opinion on Pharmacotherapy·Panagiotis Poulikakos, Matthew E Falagas
Nov 20, 2013·Nigerian Medical Journal : Journal of the Nigeria Medical Association·Olusola Ayodele Sogebi
Jul 31, 2014·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Ismail KocyigitBulent Tokgoz
Jan 22, 2015·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Cheng CuiXin Qin

❮ Previous
Next ❯

Citations

May 16, 2020·Tuberculosis Research and Treatment·Dawit A Ejigu, Solomon M Abay

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

SPSS Statistics

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.